The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of the PI3K inhibitor BKM120 monotherapy in patients with advanced or recurrent endometrial carcinoma: ENDOPIK, GINECO Study.
 
Pierre-Etienne Heudel
No Relationships to Disclose
 
Michel Fabbro
No Relationships to Disclose
 
Celia Roemer-Becuwe
No Relationships to Disclose
 
Isabelle Treilleux
No Relationships to Disclose
 
Marie-Christine Kaminsky
No Relationships to Disclose
 
Antoine Arnaud
No Relationships to Disclose
 
Florence Joly
Travel, Accommodations, Expenses - Novartis
 
Sophie Roche Forestier
No Relationships to Disclose
 
Robert Herve
No Relationships to Disclose
 
Isabelle Ray-Coquard
Research Funding - PharmaMar; Roche Pharma AG
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Roche Pharma AG